Zydus Cadila Healthcare Limited Revenue and Competitors
Estimated Revenue & Valuation
- Zydus Cadila Healthcare Limited's estimated annual revenue is currently $3.5M per year.
- Zydus Cadila Healthcare Limited's estimated revenue per employee is $2,313
Employee Data
- Zydus Cadila Healthcare Limited has 1513 Employees.
- Zydus Cadila Healthcare Limited grew their employee count by -3% last year.
Zydus Cadila Healthcare Limited's People
Name | Title | Email/Phone |
---|---|---|
1 | PA to The President | Reveal Email/Phone |
2 | IT Officer | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
4 | Executive Officer | Reveal Email/Phone |
5 | Officer | Reveal Email/Phone |
6 | Trainee officer | Reveal Email/Phone |
7 | Security Officer | Reveal Email/Phone |
8 | SVP - Head Demand Fulfillment | Reveal Email/Phone |
9 | Officer | Reveal Email/Phone |
10 | Security Officer | Reveal Email/Phone |
What Is Zydus Cadila Healthcare Limited?
Zydus Cadila Healthcare Limited is a biotechnology company based out of Zydus Tower Opp Fun Republic Satellite Cross Roads Satellite Road, Ahmedabad, Gujarat, India.
keywords:N/AN/A
Total Funding
1513
Number of Employees
$3.5M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Zydus Cadila Healthcare Limited News
... Limited, Pfizer Inc., Globe Pharmaceuticals, Delta Pharma Limited, ... Octagon Chemicals Limited, APINO PHARMA CO., LTD., Zydus Cadila,...
... OPKO Health Inc., Sarepta Therapeutics Inc., Takeda Pharmaceutical Company Limited, Visterra Inc., Zydus Cadila Healthcare Limited.
... Ipca Laboratories, Zydus Cadila, Sanofi S.A., McW Healthcare, Macleods Pharmaceuticals Ltd, Cipla Limited, Lupin Limited, Mylan N.V., Abbott India Ltd.
www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete. Reference ID IP Address Date and Time 7b6c401d4a92eeb62dcf1d26bc03e483 3.138.189.47 11/18/2021 05:12 AM UTC Attachments ...
Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection Ahmedabad, India, 10 November, 2021 Zydus Cadila has received final approval from the USFDA to market Glycopyrrolate Injection in the strengths of 0.2 mg/mL and 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Vials and 1 mg/5 mL ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $309.8M | 1526 | 5% | N/A |
#2 | $167.9M | 1671 | 7% | N/A |
#3 | $343.3M | 1691 | 9% | N/A |
#4 | $312.3M | 1716 | 9% | N/A |
#5 | $391.4M | 1928 | 11% | N/A |